Characterization of amylin binding sites in a human hepatoblastoma cell line
- PMID: 1337379
- DOI: 10.1016/0196-9781(92)90028-2
Characterization of amylin binding sites in a human hepatoblastoma cell line
Abstract
Amylin binding sites in a human hepatoblastoma cell line (HepG2) have been characterized in detail. 125I-Amylin (rat) bound to HepG2 cells with high affinity. Binding was reversible and selective, and dependent on time and temperature. Scatchard analysis revealed the presence of high (Kd = 0.11 +/- 0.04 nM) and low (Kd = 1.3 +/- 0.4 microM) affinity binding sites for 125I-amylin in HepG2 cells. The dissociation experiments also showed that 125I-amylin dissociated from high- and low-affinity sites. The association data, however, indicated the presence of only one binding site. Rat amylin was more potent than human amylin and rat calcitonin gene-related peptide (CGRP) in displacing 125I-amylin bound to HepG2 cells. Nonhomologous peptides did not displace 125I-amylin. Rat amylin was, however, less potent than rat CGRP in displacing 125I[Tyr0]CGRP from HepG2 cells. Pretreatment of HepG2 cells with rat amylin (10 nM) reduced the specific binding of 125I-amylin by 75%, whereas rat CGRP (10 nM) pretreatment had no effect on amylin binding. Calcitonin gene-related peptide, as well as rat and human amylin, stimulated the adenylate cyclase activity of HepG2 cell membrane preparation in a dose-dependent manner, with an order of potency of CGRP > rat amylin > human amylin. A CGRP antagonist, CGRP(8-37), significantly attenuated the stimulatory effect of both amylin and CGRP on adenylate cyclase activity. These investigations show that distinct receptors of amylin and CGRP are present in HepG2 cells, and that amylin stimulates adenylate cyclase activity through CGRP receptors. This system could now be exploited for studying amylin receptors and amylin-mediated signal transduction.
Similar articles
-
Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.Endocrinology. 1997 Aug;138(8):3486-96. doi: 10.1210/endo.138.8.5312. Endocrinology. 1997. PMID: 9231803
-
Differential calcitonin gene-related peptide (CGRP) and amylin binding sites in nucleus accumbens and lung: potential models for studying CGRP/amylin receptor subtypes.J Neurochem. 1995 Sep;65(3):1131-8. doi: 10.1046/j.1471-4159.1995.65031131.x. J Neurochem. 1995. PMID: 7643091
-
A mnemonical or negative-co-operativity model for the activation of adenylate cyclase by a common G-protein-coupled calcitonin-gene-related neuropeptide (CGRP)/amylin receptor.Biochem J. 1993 Jul 1;293 ( Pt 1)(Pt 1):229-36. doi: 10.1042/bj2930229. Biochem J. 1993. PMID: 8392334 Free PMC article.
-
Regulation of hepatocyte adenylate cyclase by amylin and CGRP: a single receptor displaying apparent negative cooperatively towards CGRP and simple saturation kinetics for amylin, a requirement for phosphodiesterase inhibition to observe elevated hepatocyte cyclic AMP levels and the phosphorylation of Gi-2.J Cell Biochem. 1994;55 Suppl:66-82. doi: 10.1002/jcb.240550008. J Cell Biochem. 1994. PMID: 7929619 Review.
-
Pharmacology of receptors for calcitonin gene-related peptide and amylin.Trends Pharmacol Sci. 1995 Dec;16(12):424-8. doi: 10.1016/s0165-6147(00)89093-8. Trends Pharmacol Sci. 1995. PMID: 8578616 Review.
Cited by
-
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families.Cancers (Basel). 2023 Mar 9;15(6):1694. doi: 10.3390/cancers15061694. Cancers (Basel). 2023. PMID: 36980580 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials